| Title | Date |
|---|
| Flu Vaccines—2009-2010 | Nov 19, 2009 |
| Pregnancy Study Shows Increase in C-Sections and Slightly Lower Fetal Size among Women with MS | Nov 18, 2009 |
| New Data Support Early Interferon Treatment for Multiple Sclerosis | Nov 12, 2009 |
| Harvard Study Links Teen Obesity in Girls to Increased Risk of Developing MS | Nov 11, 2009 |
| Minimally Invasive Radiosurgery May Improve MS Facial Pain that Does Not Respond to Drugs | Nov 11, 2009 |
| Fast Forward Think Tank Explores Personalized Medicine and the Translation of High-Tech Lab Discoveries to Improving Treatment of MS | Nov 09, 2009 |
| MS Trial Alert: Study of Oral Teriflunomide (HMR1726) Recruiting People with Relapsing Forms of MS Worldwide | Nov 09, 2009 |
| MS Trial Alert: Recruiting Nationwide for Study of Copaxone in Patients with First Episode of Acute Optic Neuritis | Nov 05, 2009 |
| Society-Funded Researchers Show that Early Relapses Link to MS Progression | Nov 05, 2009 |
| Update on Tysabri and PML: Company Releases Details of Cases and Risks | Oct 29, 2009 |
| Results Published from Rituximab Study in Primary-Progressive MS | Oct 29, 2009 |
| 26 New Research Projects Launched Totaling $9.2 Million To Propel Multiple Sclerosis Research | Oct 26, 2009 |
| European Drug Agency to Weigh Risks/Benefits of Tysabri -- cites 23 cases of PML | Oct 23, 2009 |
| Researchers Show How Immune Attack May Directly Damage Nerve Fibers in MS | Oct 21, 2009 |
| Case report: Person treated with Tysabri for MS develops brain cancer (primary central nervous system lymphoma) | Oct 15, 2009 |
| Panel Recommends that FDA Approve Fampridine-SR (proposed name Amaya) for Symptomatic Treatment of MS (UPDATED) | Oct 14, 2009 |
| PreCISe Study Results – Showing Benefit of Copaxone® in People at High Risk for MS – Published | Oct 07, 2009 |
| Research into Blood Flow in the Brain and Venous Insufficiency, or CCSVI, in MS | Oct 06, 2009 |
| Fast Forward Announces Collaborative Alliance with the Accelerated Cure Project, a National Nonprofit Organization, to Support ACP’s Tissue Repository Program | Sep 30, 2009 |
| Sponsor applies to FDA for approval of oral Cladribine for relapsing MS – approval would mean first oral disease-modifying therapy for MS (UPDATED) | Sep 30, 2009 |
| Positive Results Announced from Phase 3 Trial of Fingolimod Pills in Relapsing MS | Sep 30, 2009 |
| MS Trial Alert: Study of Oral Teriflunomide (HMR1726) Recruiting People at High Risk for MS Worldwide | Sep 29, 2009 |
| Therapeutic Strategies for MS and More Highlighted at ECTRIMS Conference (UPDATED) | Sep 22, 2009 |
| Update on Tysabri and PML | Sep 18, 2009 |
| MS Trial Alert: Investigators Recruiting for Study of Duloxetine Hydrochloride to Treat Neuropathic Pain in MS | Sep 14, 2009 |
| International Team Refutes Finding of Evidence of Epstein-Barr Virus in Brains of People with MS | Aug 31, 2009 |
| MS Trial Alert: Investigators Recruiting 1260 People with MS for Study of PEGylated Interferon Beta-1a | Aug 31, 2009 |
| Fast Forward Contracts With IntraLinks to Accelerate and Facilitate Its Drug Funding Decisions | Aug 27, 2009 |
| New Studies Associate Smoking with Tissue Damage and Disease Development in People with MS | Aug 27, 2009 |
| National MS Society-Funded Study Shows Diabetes Drug Improves Mice with MS-Like Disease | Aug 27, 2009 |
| Fast Forward, LLC and Amplimmune, Inc. Join Forces To Speed New Treatment to People With MS | Aug 25, 2009 |
| Drug Used for High Blood Pressure Shows Benefits in Treating MS-like Disease in Mice | Aug 18, 2009 |
| New Brand of Interferon Beta for Treating MS Approved by FDA | Aug 18, 2009 |
| Sponsor Reports Positive Results of Clinical Trial of Zenvia™ for Pseudobulbar Affect (Uncontrollable Laughing and/or Crying) | Aug 14, 2009 |
| MS-like Disease in Mice Suppressed by Fusing Two Immune Proteins | Aug 14, 2009 |
| Care Given to People with MS by Family Members Presents Unique Challenges - Study funded by National MS Society points to need for respite and mental health support for family care givers | Aug 11, 2009 |
| Disappointing Results from Phase 3 Clinical Trial of Dirucotide (MBP8298) in Secondary-Progressive MS -- Companies announce halt to ongoing trials of dirucotide in MS | Jul 29, 2009 |
| NIH Deepens Investment in Combination Study of MS Drugs | Jul 20, 2009 |
| Study Adds Evidence that Smoking Worsens MS, and Quitting May Help | Jul 16, 2009 |
| MS Trial Alert: Small Study Recruiting People with MS and Spasticity to Compare IPX056 (Extended-release Baclofen) and Immediate-release Baclofen | Jul 14, 2009 |
| Team Funded by National MS Society’s Promise: 2010 Campaign Identifies Key Signals in Myelin Repair | Jul 13, 2009 |
| Clinical Trial of Oral CDP323 in Relapsing MS Discontinued | Jul 13, 2009 |
| “Benign” Course of MS Evaluated with MRI and Other Imaging Methods by European Collaborators | Jul 08, 2009 |
| MS Trial Alert: Recruiting Patients for Study on How Adhering to Therapy Impacts MS | Jun 25, 2009 |
| Two Studies Report Finding New Genes and Gene Regions that Make People Susceptible to MS | Jun 22, 2009 |
| Two Medical Meetings (ACTRIMS and CMSC) Focus on MS Risk Factors and Quality of Life Issues | Jun 10, 2009 |
| Study: Breastfeeding May Reduce Likelihood of Postpartum MS Attacks | Jun 10, 2009 |
| MS Trial Alert: Sites in Ohio, Texas, and Washington Recruiting for a Small Study of Autologous ("Self") Hematopoietic Stem Cell Transplant Underway | May 26, 2009 |
| Positive Clinical Trial Results Take Center Stage at American Academy of Neurology Meeting (UPDATED) | May 22, 2009 |
| Clinical Trials in Multiple Sclerosis 2009 | May 19, 2009 |
| Detecting Nervous System Repair in MS: International Workshop Findings Published | May 18, 2009 |
| Fast Forward, LLC, Seeking Proposals in Early Stage Drug Development for MS | May 07, 2009 |
| Fast Forward, LLC and Provid Pharmaceuticals Announce Partnership for Development of PV-267, A Unique Compound Intended to Redirect the Abnormal Immune Response In Multiple Sclerosis | May 05, 2009 |
| Dr. David Miller, Pioneer in MS Imaging, Awarded 2009 John Dystel Prize | Apr 28, 2009 |
| Is it Multiple Sclerosis or a Look-Alike? International Society Task Force Offers Guidelines for Diagnosing MS and its Mimics | Apr 23, 2009 |
| MS Trial Alert: Study of Oral Cladribine Added on to Interferon Therapy Recruiting Worldwide | Apr 01, 2009 |
| New Study Reports Reduced Overall Cancer Risk in People with MS | Mar 30, 2009 |
| New Studies Bolster Possible Link Between Epstein-Barr Virus and MS | Mar 05, 2009 |
| Genetics Studies Yield New Clues to Why People Get MS | Mar 05, 2009 |
| FDA Extends Copaxone Labeling To Include Those Experiencing First Attack and Having MRI Scan Suggestive Of MS | Mar 05, 2009 |
| Society Convenes Workshop on Strategies to Find Cause of MS, Factors Driving Progression, and Ways to Estimate MS Frequency | Mar 04, 2009 |
| Positive Results Published of First of Two Phase 3 Clinical Trials of Fampridine-SR | Feb 26, 2009 |
| Studies on the Risks of Smoking and Potential Benefits of Breast Feeding Released in Advance of American Academy of Neurology Meeting | Feb 23, 2009 |
| FDA Agrees to Fast Review for Oral Drug Being Tested for MS | Feb 12, 2009 |
| MS Trial Alert: Clinical Trial of Sex Hormone Estriol Recruiting Women with MS to Participate - Updated | Feb 10, 2009 |
| MS Trial Alert: Researchers Recruiting People with Early MS in San Francisco Bay Area for Study of Riluzole for Neuroprotection | Feb 10, 2009 |
| Tysabri Update: New Published Papers Explore its Benefits, and New Case of PML Reported | Feb 10, 2009 |
| Study Shows Link Between Vitamin D and an MS Susceptibility Gene | Feb 06, 2009 |
| Promise: 2010 Nervous System Repair Teams Meet, Plan Next Steps Toward Restoring Nerve Function in People with MS | Feb 04, 2009 |
| Study Reports That Plasma Exchange Can Clear Tysabri from Blood; No Evidence Yet That This Can Help Treat PML | Feb 03, 2009 |
| Dirucotide (MBP8298) Did Not Reduce Relapses in Phase 2 Study in Relapsing-Remitting MS: Phase 3 Studies Underway in Secondary-Progressive MS | Feb 02, 2009 |
| Researchers Report Good Results from Small Study of Stem Cell Therapy to “Reboot” Immune System in MS | Jan 29, 2009 |
| Media reports focus on Botox® as a symptomatic treatment for MS | Jan 29, 2009 |
| Oral Cladribine Reduces MS Relapses in Phase 3 Clinical Trial | Jan 23, 2009 |
| Researchers Use Advanced Imaging Tools to Shed New Light on MS | Jan 16, 2009 |
| Licensing agreement signed between Apitope and Merck Serono is good news for Fast Forward and the development of the ATX-MS-1467 therapy | Jan 14, 2009 |
| Teva Neuroscience Launching New Needle for Copaxone | Dec 26, 2008 |
| Fast Forward, LLC, Announces $1 Million Sponsored Research Agreement to Fund Proof of Principle Clinical Trial for Therapeutic Vaccine | Dec 23, 2008 |
| Researchers Funded in Part by Society’s Promise:2010 Campaign Use Novel Technology to Identify Antibody Patterns in Blood Samples from People with MS | Dec 19, 2008 |
| IVIG Shows Mixed Results in Two Studies | Dec 18, 2008 |
| Oral FTY720 (Fingolimod) Reduced Relapse Rate More Effectively Than Avonex in Initial Results of One-Year Study in Relapsing-Remitting MS | Dec 12, 2008 |
| Think Tank Examines How to Turn More Lab Discoveries into New Therapies for Progressive MS | Dec 12, 2008 |
| Great Strides Moved MS Research Forward During 2008 | Dec 02, 2008 |
| Young MS Researchers Shine at First-Ever Tykeson Fellows Conference on MS | Dec 02, 2008 |